EVERSANA, a pharma commercialization company, and Waltz Health, a digital prescription drug company, are merging into a $6 billion entity, they announced on Tuesday.

Chicago-based EVERSANA serves more than 650 pharmaceutical and biotech companies and helps them bring therapies to market. Its services include the distribution of inventory and marketing and advertising to physicians. It also helped Eli Lilly with the creation of LillyDirect, a direct-to-consumer platform that allows patients to access certain Eli Lilly medications, including the GLP-1 Zepbound.

Waltz Health , also based in Chicago, serves payers, employers and pharmacies. It has a platform called Waltz Connect, which matches patients to the most suitable pharmacy for them when they’re prescribed a specialty medication

See Full Page